Literature DB >> 30236126

Hyperoxia effects on intensive care unit mortality: a retrospective pragmatic cohort study.

Mathilde Ruggiu1, Nadia Aissaoui2,3,4, Julien Nael2, Caroline Haw-Berlemont2, Bertrand Herrmann2, Jean-Loup Augy2, Sofia Ortuno2, Damien Vimpère2,3, Jean-Luc Diehl2,3, Clotilde Bailleul2,3, Emmanuel Guerot2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30236126      PMCID: PMC6148961          DOI: 10.1186/s13054-018-2142-6

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
Supplementary oxygen is frequent in the management of patients admitted to the intensive care unit (ICU) [1]. However, some studies have suggested deleterious effects of hyperoxia on these patients [2-4]. This main study objective was to assess the association between hyperoxia, at any time of the ICU stay, and ICU mortality regardless of the cause of patient admission. Our study was an observational, retrospective, and single-centre study in the Hôpital Européen George Pompidou medical ICU, Paris, France. All patients admitted between November and December 2017 were included regardless of their admission cause and all of their arterial blood gases (ABGs) were analysed. Hyperoxia was defined as a partial arterial pressure in oxygen (PaO2) superior to 100 mmHg (13.3 kPa). The principal judgement criterion was occurrence of at least one hyperoxia episode during the ICU stay. All statistical tests were two-tailed with a significance threshold of 0.05. Analyses were performed with R v3.2.4. Survival analysis was estimated by Kaplan–Meier methods. A total of 130 patients, median age 68 (57–79) years and median SAPS II 45 (35–56), were included. The mean reason for ICU admission was respiratory failure (60 patients, 46%) and 83 patients (64%) needed mechanical ventilation. Thirty-five patients (27%) died during their ICU stay. Eighty patients (62%) presented at least one episode of hyperoxia. Overall survival (OS) was significantly lower in patients who presented at least one episode of hyperoxia during their ICU stay: median OS was 26 days (95% CI 20–NR) versus median not reached, p = 0.0047 (Fig. 1).
Fig. 1

Kaplan–Meier estimation of overall survival. Hyperoxia group, patients who presented at least one hyperoxia episode during ICU stay. No hyperoxia group, patients who presented no hyperoxia episode during ICU stay. Overall survival median in hyperoxia group 26 days (95% CI 20–NR); overall survival median in no hyperoxia group not reached. ICU intensive care unit

Kaplan–Meier estimation of overall survival. Hyperoxia group, patients who presented at least one hyperoxia episode during ICU stay. No hyperoxia group, patients who presented no hyperoxia episode during ICU stay. Overall survival median in hyperoxia group 26 days (95% CI 20–NR); overall survival median in no hyperoxia group not reached. ICU intensive care unit In univariate analysis, hyperoxia was a risk factor for mortality: 31 deceased patients presented hyperoxia (89%) versus 49 alive patients (52%), p < 0.001. SAPS II and mechanical ventilation time were also mortality risk factors in univariate analysis (Additional file 1: Table S1). Multivariate analysis showed that hyperoxia was an independent risk factor for ICU mortality: OR = 3.80 (95% CI 1.08–16.01), p = 0.047 (Table 1).
Table 1

Mortality risk factors in the medical ICU, multivariate analysis

Mortality risk factorDeceased (n = 35)Alive (n = 95)Odds ratio (95% CI) p
Age (years)70 (66–75)65 (61–69)0.15
SAPS II64 (56–72)41 (37–45)< 0.001
Mechanical ventilation time9 (7–12)5 (3–7)0.074
At least one PaO2 > 100 mmHg (13.3 kPa)31 (89%)49 (52%)3.80 (1.08–16.01)0.047

Data presented as mean (95CI) or n (%)

R2 = 0.453

CI confidence interval, ICU intensive care unit, PaO partial arterial pressure in oxygen, SAPS II Simplified Acute Physiology Score II

Mortality risk factors in the medical ICU, multivariate analysis Data presented as mean (95CI) or n (%) R2 = 0.453 CI confidence interval, ICU intensive care unit, PaO partial arterial pressure in oxygen, SAPS II Simplified Acute Physiology Score II Despite a conservative oxygen policy, 62% of patients presented at least one episode of hyperoxia, which reinforces the statement by Helmerhorst et al. [5]. Previous studies had a focus on specific categories of selected patients [2-4]. On the contrary, our study is a pragmatic study in real-life conditions. We included all consecutive patients admitted to the medical ICU without any exclusion criteria, regardless of the admission cause, mechanical ventilation need, or initial severity, and we collected prospectively a large amount of 1.450 ABG. In this study, we demonstrated that hyperoxia at any time of the ICU stay significantly decreases OS and is an independent mortality risk factor. Table S1. Mortality risk factors in medical ICU, univariate analysis. (DOCX 17 kb)
  3 in total

1.  Current oxygenation practice in ventilated patients-an observational cohort study.

Authors:  R Panwar; G Capellier; N Schmutz; A Davies; D J Cooper; M Bailey; D Baguley; V Pilcher; R Bellomo
Journal:  Anaesth Intensive Care       Date:  2013-07       Impact factor: 1.669

Review 2.  Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of Cohort Studies.

Authors:  Hendrik J F Helmerhorst; Marie-José Roos-Blom; David J van Westerloo; Evert de Jonge
Journal:  Crit Care Med       Date:  2015-07       Impact factor: 7.598

Review 3.  Harmful Effects of Hyperoxia in Postcardiac Arrest, Sepsis, Traumatic Brain Injury, or Stroke: The Importance of Individualized Oxygen Therapy in Critically Ill Patients.

Authors:  Jean-Louis Vincent; Fabio Silvio Taccone; Xinrong He
Journal:  Can Respir J       Date:  2017-01-26       Impact factor: 2.409

  3 in total
  4 in total

Review 1.  Oxygen Toxicity in Critically Ill Adults.

Authors:  Chad H Hochberg; Matthew W Semler; Roy G Brower
Journal:  Am J Respir Crit Care Med       Date:  2021-09-15       Impact factor: 30.528

2.  Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced Acute Inflammatory Lung Injury by Enhancing Macrophage Function via Reducing the Accumulation of Airway HMGB1.

Authors:  Vivek Patel; Katelyn Dial; Jiaqi Wu; Alex G Gauthier; Wenjun Wu; Mosi Lin; Michael G Espey; Douglas D Thomas; Charles R Ashby; Lin L Mantell
Journal:  Int J Mol Sci       Date:  2020-02-01       Impact factor: 5.923

3.  The Association between Supraphysiologic Arterial Oxygen Levels and Mortality in Critically Ill Patients. A Multicenter Observational Cohort Study.

Authors:  Edward Palmer; Benjamin Post; Roman Klapaukh; Giampiero Marra; Niall S MacCallum; David Brealey; Ari Ercole; Andrew Jones; Simon Ashworth; Peter Watkinson; Richard Beale; Stephen J Brett; J Duncan Young; Claire Black; Aasiyah Rashan; Daniel Martin; Mervyn Singer; Steve Harris
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

4.  Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study.

Authors:  Yue Yu; Ren-Qi Yao; Yu-Feng Zhang; Su-Yu Wang; Wang Xi; Jun-Nan Wang; Xiao-Yi Huang; Yong-Ming Yao; Zhi-Nong Wang
Journal:  Mil Med Res       Date:  2021-07-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.